Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001728955-21-000002
Filing Date
2021-11-10
Accepted
2021-11-10 11:31:48
Documents
1
Effectiveness Date
2021-11-10
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8250
  Complete submission text file 0001728955-21-000002.txt   9308
Mailing Address 780 THIRD AVE. 18TH FLOOR NEW YORK NY 10017
Business Address 780 THIRD AVE. 18TH FLOOR NEW YORK NY 10017 410-659-2777
Dracen Pharmaceuticals, Inc. (Filer) CIK: 0001728955 (see all company filings)

EIN.: 812597193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-420647 | Film No.: 211395371